# Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma

> **NCT03800212** · — · UNKNOWN · sponsor: **Federation Francophone de Cancerologie Digestive** · enrollment: 402 (estimated)

## Conditions studied

- Ampullary Adenocarcinoma

## Interventions

- **DRUG:** treatment for ampullary adenocarcinoma

## Key facts

- **NCT ID:** NCT03800212
- **Lead sponsor:** Federation Francophone de Cancerologie Digestive
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-07
- **Primary completion:** 2022-12-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 402 (ESTIMATED)
- **Last updated:** 2022-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03800212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03800212, "Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03800212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*